扁蒴藤素提高人食管鳞状细胞癌耐药细胞株ECA109/DDP的顺铂敏感性OA
Pristimerin sensitizes human esophageal squamous cell carcinoma cell strain ECA109/DDP to cisplatin
目的 探讨扁蒴藤素对食管鳞状细胞癌细胞系 ECA109 顺铂(DDP)敏感性的作用机制.方法 20 μg/mL DDP 处理 ECA109 细胞,每 2~3 代递增药物浓度(40、80、100 μg/mL),持续 3~6 个月直至细胞在高浓度 DDP(80 μg/mL)下稳定增殖,即获得 DDP 稳定耐药株 ECA109/DDP.将 ECA109/DDP 细胞分为对照组(溶剂对照)、DDP(80 μg/mL)组、扁蒴藤素(1 μmol/L)组、扁蒴藤素(1 μmol/L)+DDP(80 μg/mL)组、扁蒴藤素(1 μmol/L)+DDP(80 μg/mL)+TGF-β 激活剂(SRI-011381)(10 μmol/L)组.CCK-8法和集落形成实验检测细胞增殖;流式细胞测量术检测细胞凋亡;划痕实验、Transwell 小室法分别检测细胞迁移、侵袭;Western blot 检测细胞多药耐药相关蛋白 1(MRP1)、P-糖蛋白(P-gp)、转化生长因子-β1(TGF-β1)、Smad4、CD44 蛋白表达.结果 与对照组相比,DDP 组各指标差异无统计学意义,扁蒴藤素组 A450值、集落形成率、划痕愈合率、细胞侵袭数减少(P<0.05);MRP1、P-gp、TGF-β1、Smad4、CD44 蛋白表达降低,细胞凋亡率增加(P<0.05);与 DDP 组、扁蒴藤素组相比,扁蒴藤素+DDP 组A450值、集落形成率、划痕愈合率、细胞侵袭数减少,MRP1、P-gp、TGF-β1、Smad4、CD44 蛋白表达降低,细胞凋亡率增加(P<0.05);与扁蒴藤素+DDP 组相比,扁蒴藤素+DDP+SRI-011381 组上述指标变化趋势相反(P<0.05).结论 扁蒴藤素可通过抑制 TGF-β/Smad 通路增强 ECA109/DDP 细胞 DDP 敏感性.
Objective To investigate the mechanism by which pristimerin enhances cis-diamine dichloroplatinum/cisplatin(DDP)sensitivity of esophageal squamous cell carcinoma cell line ECA109.Methods ECA109 cells were treated with 20 μg/mL DDP,with drug concentrations incrementally increased(40,80,100 μg/mL)every 2-3 passages.After 3-6 months,stable DDP-resistant ECA109/DDP cells were obtained which proliferated in high DDP concentration environment(80 μg/mL).The ECA109/DDP cells were divided into the following groups:control,DDP(80 μg/mL),pristimerin(1 μmol/L),pristimerin(1 μmol/L)+DDP(80 μg/mL),and pristimerin(1 μmol/L)+DDP(80 μg/mL)+TGF-β activator(SRI-011381)(10 μmol/L).Cell proliferation was assessed by CCK-8 assay and colony formation test;Apoptosis was examined by flow cytometry;Migration and invasion were evaluated via scratch wound healing and Transwell assays,respectively.The protein expressions of multidrug re-sistance-associated protein 1(MRP1),P-glycoprotein(P-gp),TGF-β1,Smad4,and CD44 were measured by Western blot.Results Compared with control group,there was no difference in various indicators in the DDP group(P<0.05).While pristimerin group exhibited a decrease of A450 values,colony formation rate,scratch healing rate,number of invasive cells.The protein level of MRP1,P-gp,TGF-β1,Smad4,and CD44 also de-creased,along with increased apoptosis(P<0.05).Compared with the DDP and pristimerin groups,the pristim-erin+DDP group showed further reduction in A450 values,colony formation rate,scratch healing rate,number of invasive cells,and protein level of MRP1,P-gp,TGF-β1,Smad4,and CD44,as well as increased apoptosis(P<0.05).Compared with pristimerin+DDP group,pristimerin+DDP+SRI-011381 group showed an opposite trend in all the above indicators(P<0.05).Conclusions Pristimerin enhances DDP sensitivity in ECA109/DDP cells by inhibition of TGF-β/Smad pathway.
刘桂举;袁威;吕鼎霖;韩倩倩;梅家转;张浩哲
郑州人民医院 肿瘤内科,河南 郑州 450000郑州人民医院 肿瘤内科,河南 郑州 450000郑州人民医院 肿瘤内科,河南 郑州 450000郑州人民医院 肿瘤内科,河南 郑州 450000郑州人民医院 肿瘤内科,河南 郑州 450000郑州人民医院 肿瘤内科,河南 郑州 450000
医药卫生
扁蒴藤素食管鳞状细胞癌顺铂化学药物治疗敏感性增殖
pristimerinesophageal squamous cell carcinomacisplatinchemosensitivityproliferation
《基础医学与临床》 2026 (9)
1200-1206,7
河南省医学科技攻关计划联合共建项目(LHGJ20230723)
评论